DEVELOPMENT OF ANTICERAMIDE TREATMENT AS A NOVEL MEDICAL COUNTERMEASURE FOR ACUTE EFFECTS OF RADIATION EXPOSURE
$1,529,485
| Recipient | CERAMEDIX HOLDING, LLC UEI JLZSJRJVKJ49 |
|---|---|
| Award ID | 75N93023C00015 |
| Award amount | $1,529,485 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN12 |
| Start date | Jul 1, 2023 |
| End date | Aug 31, 2024 |
| Place of performance | NEW YORK, NY |
| Record updated | Aug 22, 2023 |
View the official award record
More awards won by CERAMEDIX HOLDING, LLC
JW190496 FY19 NEW START
Department of Defense · $4,496,897 · Sep 28, 2020
DEVELOPMENT OF RADIATION/NUCLEAR MEDICAL COUNTERMEASURES (MCMS) AND BIODOSIMETRY DEVICES. 7-1/2026 TO 6/30/2026. DAP-NCAP-00000073.
Department of Health and Human Services · $1,500,000 · Jul 1, 2026
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids